Lobbying

Arcardium Lithium (Formally Known Aslivent's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q4 2022.

Arcardium Lithium (Formally Known Aslivent

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

Arcardium Lithium (Formally Known Aslivent lobbying by quarter
Arcardium Lithium (Formally Known Aslivent lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

No issue reported.

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

No house or agency named.

Firms it paid

Firm
Red Flag Consulting USA$010 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
25/04/23for Q1 2025Red Flag Consulting USAUnder $5,000
25/02/04for Q4 2024Red Flag Consulting USAUnder $5,000
24/10/15for Q3 2024Red Flag Consulting USAUnder $5,000
24/08/13for Q2 2024Red Flag Consulting USAUnder $5,000
24/05/03for Q1 2024Red Flag Consulting USAUnder $5,000
24/05/03for Q1 2024Red Flag Consulting USAUnder $5,000
24/02/06for Q4 2023Red Flag Consulting USAUnder $5,000
23/11/14for Q3 2023Red Flag Consulting USAUnder $5,000
23/08/08for Q2 2023Red Flag Consulting USAUnder $5,000
23/05/04for Q1 2023Red Flag Consulting USAUnder $5,000
23/02/10for Q4 2022Red Flag Consulting USAUnder $5,000